2:30 pm
3:30 pm
Room 14
Sponsored symposia: AstraZeneca UK. This is a promotional symposium sponsored and organised by AstraZeneca, intended for GB HCPs only.
Savefor later Page saved! You can go back to this later in your Diabetes and Me Close

Cardiorenal risk based-management in T2DM: the latest standard of care

This is a promotional symposium sponsored and organised by AstraZeneca, intended for GB HCPs only.     

Chair: James Burton, Leicestershire                                 

Speakers: Sarah Birkhoelzer, Oxford                                            

Vinod Patel, Warwickshire  

This session covers the impact of type 2 diabetes on the cardiorenal system and the rationale for implementing a risk-based approach in primary care. You will hear the perspective of a diabetologist, cardiologist and nephrologist on when and why to initiate NICE-recommended therapies.

AstraZeneca has provided sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia.    

Please note that this session is not eligible for accreditation. 

Savefor later Page saved! You can go back to this later in your Diabetes and Me Close

Share this Page

FacebookWhatsappTwitterPinterestEmailPrint
Back to Top
Brand Icons/Telephonecheck - FontAwesome““icons/tickicons/uk